Michael Mroß

770 total citations
14 papers, 486 citations indexed

About

Michael Mroß is a scholar working on Genetics, Epidemiology and Oncology. According to data from OpenAlex, Michael Mroß has authored 14 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Epidemiology and 3 papers in Oncology. Recurrent topics in Michael Mroß's work include Inflammatory Bowel Disease (9 papers), Microscopic Colitis (7 papers) and Gastrointestinal motility and disorders (3 papers). Michael Mroß is often cited by papers focused on Inflammatory Bowel Disease (9 papers), Microscopic Colitis (7 papers) and Gastrointestinal motility and disorders (3 papers). Michael Mroß collaborates with scholars based in Germany, United Kingdom and Belgium. Michael Mroß's co-authors include Séverine Vermeire, L Altenhofen, Andreas Adler, David A. Lieberman, R Drossel, Bertram Wiedenmann, Michael Mayr, G Stange, Jens Aschenbeck and Ulrich Gauger and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Michael Mroß

11 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Mroß Germany 8 253 204 201 172 169 14 486
Hideharu Okanobu Japan 13 77 0.3× 62 0.3× 145 0.7× 278 1.6× 204 1.2× 35 461
Phillip Fleshner United States 9 136 0.5× 81 0.4× 103 0.5× 81 0.5× 225 1.3× 43 391
Přemysl Falt Czechia 13 62 0.2× 68 0.3× 352 1.8× 299 1.7× 271 1.6× 65 539
Motohiro Esaki Japan 12 189 0.7× 128 0.6× 44 0.2× 286 1.7× 432 2.6× 30 654
Lars Karlsen Norway 8 112 0.4× 220 1.1× 114 0.6× 50 0.3× 67 0.4× 19 432
Evangelos Voudoukis Greece 7 62 0.2× 37 0.2× 177 0.9× 188 1.1× 94 0.6× 27 318
Elia Armellini Italy 15 85 0.3× 170 0.8× 253 1.3× 172 1.0× 261 1.5× 25 496
W. A. Bemelman Netherlands 11 122 0.5× 96 0.5× 173 0.9× 81 0.5× 453 2.7× 29 608
Howard Smart United Kingdom 10 55 0.2× 121 0.6× 248 1.2× 77 0.4× 320 1.9× 31 471
Paul J. Kingma Netherlands 4 89 0.4× 276 1.4× 41 0.2× 240 1.4× 315 1.9× 8 553

Countries citing papers authored by Michael Mroß

Since Specialization
Citations

This map shows the geographic impact of Michael Mroß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mroß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mroß more than expected).

Fields of papers citing papers by Michael Mroß

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Mroß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mroß. The network helps show where Michael Mroß may publish in the future.

Co-authorship network of co-authors of Michael Mroß

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Mroß. A scholar is included among the top collaborators of Michael Mroß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Mroß. Michael Mroß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
3.
Kießlich, Ralf, Stefan Schubert, Michael Mroß, et al.. (2017). Efficacy and safety of PICOPREP tailored dosing compared with PICOPREP day-before dosing for colon cleansing: a multi-centric randomised study. SHILAP Revista de lepidopterología. 5(4). E282–E290. 7 indexed citations
4.
Bokemeyer, Bernd, et al.. (2016). Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency. European Journal of Drug Metabolism and Pharmacokinetics. 42(2). 229–238. 12 indexed citations
5.
Mroß, Michael, et al.. (2014). Konfessionszugehörigkeit als Selektionskriterium bei Stellenausschreibungen kirchlicher Arbeitgeber. WSI-Mitteilungen. 67(6). 478–485. 1 indexed citations
6.
Kruis, Wolfgang, et al.. (2014). Su1088 Participation in Decision Making Increases Patients' Adherence to Therapy in Ulcerative Colitis. Gastroenterology. 146(5). S–370. 1 indexed citations
7.
Mroß, Michael. (2013). Was ist Sozialmanagement? Eine Positionsbestimmung anhand einer Sammelrezension aktueller Lehrbücher. Zeitschrift für öffentliche und gemeinwirtschaftliche Unternehmen. 36(4). 336–346. 1 indexed citations
8.
Adler, Andreas, David A. Lieberman, A Aminalai, et al.. (2013). Data quality of the German Screening Colonoscopy Registry. Endoscopy. 45(10). 813–818. 24 indexed citations
9.
Hébuterne, Xavier, Marc Lémann, Yoram Bouhnik, et al.. (2012). Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol. Gut. 62(2). 201–208. 129 indexed citations
10.
Adler, Andreas, Karl Wegscheider, David A. Lieberman, et al.. (2012). Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12 134 examinations (Berlin colonoscopy project 3, BECOP-3). Gut. 62(2). 236–241. 163 indexed citations
11.
Colombel, Jean–Frédéric, Marc Lémann, Yoram Bouhnik, et al.. (2010). S1045 Endoscopic Mucosal Improvement in Patients With Active Crohn's Disease Treated With Certolizumab Pegol: Week 10 and 54 Results of the Music Trial. Gastroenterology. 138(5). S–166. 13 indexed citations
12.
Dignaß, Axel, Bernd Bokemeyer, Henning Adamek, et al.. (2009). Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 7(7). 762–769. 103 indexed citations
13.
14.
Stijnen, Theo, et al.. (2007). Pentasa (mesalazine) once or twice daily for the management of maintenance of remission of ulcerative colitis: Demographic and baseline data of a 12 month single blind randomised controlled trial. Gastroenterology. 132(4). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideharu Okanobu Breakdown of academic impact, for papers by Phillip Fleshner Breakdown of academic impact, for papers by Přemysl Falt Breakdown of academic impact, for papers by Motohiro Esaki Breakdown of academic impact, for papers by Lars Karlsen Breakdown of academic impact, for papers by Evangelos Voudoukis Breakdown of academic impact, for papers by Elia Armellini Breakdown of academic impact, for papers by W. A. Bemelman Breakdown of academic impact, for papers by Howard Smart Breakdown of academic impact, for papers by Paul J. Kingma
Rankless by CCL
2026